6EU-51801-98894
2 vaccinations
3 coded responses
3 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 104 / NY
- Registered
- 2021-10-30
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Registered dependents
E49-19096-22655
Child or adolescent in my care · Male · 2021-10-30
Timeline
-
2021-09-21
Dose 1 — Pfizer-BioNTech
-
2021-10-13
Dose 2 — Pfizer-BioNTech
-
2021-10-30
Registered in v-safe
-
2021-10-30
Survey response — day 14, dose 2MedDRA: Dizziness, Dyspnoea, Headache — Feeling: Poor · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Shortness of breath, dizzy, feeling faint, headacheMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-11-02
-
2021-11-24
Survey response — day 42, dose 2MedDRA: Asthma, Headache, Palpitations — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More palpitations, more headaches and asthma attacksMedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Survey response — 12 months, dose 2MedDRA: Asthma, COVID-19, Condition aggravated, Hypoaesthesia, Nerve injury, Parosmia, Pre-existing disease, Taste disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had COVID again recently and now I can't smell or taste right, asthma is worse; fibromyalgia and nerve damage and numbness in extremities have worsened.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-21 | Pfizer-BioNTech | No |
| 2 | 2021-10-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-30 | Unsuccessful |
Free text
Release 10 — day 14, dose 2
Symptoms: Shortness of breath, dizzy, feeling faint, headache
Release 10 — day 42, dose 2
Symptoms: More palpitations, more headaches and asthma attacks
Release 12 — 12 months, dose 2
Symptoms: Had COVID again recently and now I can't smell or taste right, asthma is worse; fibromyalgia and nerve damage and numbness in extremities have worsened.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Nerve injury | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release